VIEWPOINTS


Viewpoints are a collection of news and opinion articles that capture key research developments and important issues in the field of oncology.


Unregulated E-Cigarettes Called Unacceptable by ASCO

Unregulated E-Cigarettes Called Unacceptable by ASCO

Despite reports to the FDA regarding adverse events of e-cigarettes and concerns from health organizations, sales continue without regulatory oversight.

Partial Breast Irradiation Provides "Excellent Long-term Local Control"

Partial Breast Irradiation Provides "Excellent Long-term Local Control"

Is targeting the entire breast necessary to the success of adjuvant radiotherapy?

ASCO Releases Guideline Updates for the Use of Colony-stimulating Factors

ASCO Releases Guideline Updates for the Use of Colony-stimulating Factors

ASCO updates Clinical Practice Guidelines for the use of hematopoietic colony-stimulating factors (CSFs).

Tiny Particles May Serve as Non-Invasive Tool for Detecting Early Stage Pancreatic Cancer

Tiny Particles May Serve as Non-Invasive Tool for Detecting Early Stage Pancreatic Cancer

A non-invasive diagnostic test using the GPC1 gene may soon be used to detect pancreatic cancer and track high-risk groups.

Afatinib May Be Second-Line Option for Advanced Lung Squamous Cell Carcinoma

Afatinib May Be Second-Line Option for Advanced Lung Squamous Cell Carcinoma

Afatinib could be an additional option for the second-line treatment of patients with advanced squamous cell carcinoma of the lung.

Screening Mammography Leads to Overdiagnosis in Breast Cancer

Screening Mammography Leads to Overdiagnosis in Breast Cancer

Screening mammography does not impact the overall breast cancer death rate and can lead to overdiagnosis.

ASCO Endorses ASTRO Guidelines for Radiation Therapy Following Surgery for Endometrial Cancer

ASCO Endorses ASTRO Guidelines for Radiation Therapy Following Surgery for Endometrial Cancer

ASCO's endorsement of the ASTRO guidelines for adjuvant radiotherapy for endometrial cancer provides additional guidance for clinicians.

Management of Localized Prostate Cancer Shows Improvement

Management of Localized Prostate Cancer Shows Improvement

After a history of over treatment of low-risk prostate cancer, a new study demonstrates an increase in watchful waiting and active surveillance.

ASCO's Value Framework Emphasizes Patient-Centered Care

ASCO's Value Framework Emphasizes Patient-Centered Care

As drug prices rise, ASCO has created a formula to objectively assess costs and benefits.

New Study Identifies Multiple Genetic Changes Associated with Pancreatic Cancer

New Study Identifies Multiple Genetic Changes Associated with Pancreatic Cancer

By combining new genetic findings with data for other pancreatic cancer risk factors it may become possible to identify, screen high-risk groups.

Statin Therapy May Help Delay Prostate Cancer Progression in Men Receiving ADT

Statin Therapy May Help Delay Prostate Cancer Progression in Men Receiving ADT

Taking a statin while undergoing androgen deprivation therapy (ADT) for prostate cancer appears to pay off when it comes to delaying disease progression.

Functional Adaptive Hyperfiltration May Affect Renal Function after Radical Nephrectomy

Functional Adaptive Hyperfiltration May Affect Renal Function after Radical Nephrectomy

Adaptive hyperfiltration may be more important than structural adaptive hypertrophy for the recovery of renal function following radical nephrectomy.

Older Adults with Head and Neck Cancers May Need More Cautious Treatment Strategies

Older Adults with Head and Neck Cancers May Need More Cautious Treatment Strategies

Research from ASCO indicates treatment of locally advanced head and neck cancer should be carefully considered in patients older than 70.

ASPEN Compares Sunitinib, Everolimus in Metastatic Non-Clear Cell Renal Cell Carcinoma

ASPEN Compares Sunitinib, Everolimus in Metastatic Non-Clear Cell Renal Cell Carcinoma

Randomized trial identifies potential first-line therapy for patients with non-clear cell renal cell carcinoma.

Organoid Biobanks in Colon Cancer Show Promise in Personalized Treatment Options

Organoid Biobanks in Colon Cancer Show Promise in Personalized Treatment Options

Combining a previously established culture medium, researchers were able to create a colon tissue organoid, which could have implications for personalized treatment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs